Bill Robbins is a business owner, private investor, professional advisor and published author with more than 35 years of experience in the corporate world, start-ups, and seed-stage investing, as well as in small business and healthcare. His industry experience includes pharmaceuticals, biotechnology, medical devices, medical imaging, bioengineering, advanced materials and OTC healthcare products, as well as healthcare delivery. Through Convergent Management, Bill and his team advised more than 50 companies in fields ranging from small molecule and protein-based therapeutics, to medical devices, diagnostics, medical information technology, advanced materials, and specialty products.
As founder of Convergent Ventures, LLC and Convergent Investors, LLC Bill (with colleagues) created, funded and managed four start-ups in drug discovery and advanced materials, drawing upon intellectual property and scientific leadership from the California Institute of Technology (Caltech) and UCLA. Developing these companies entailed extensive, intense, long-term interaction and collaboration with eminent scientists, busy tech transfer offices, and research agreements with global corporations, including Pfizer, Inc., Eli Lilly, Inc. and BASF.
In 2007, Bill and a highly accomplished, Israeli-American business partner teamed-up to launch a new, California-based, seed-stage life-science fund, dedicated to creating and developing start-ups in Israel, with intellectual property sourced from the Technion - Israel Institute of Technology, the Weizmann Institute (YEDA), and other leading Israeli universities and hospitals. Unfortunately, fundraising was terminated in the midst of the 2008 financial crisis, which brought with it a career's worth of lessons about business, investing, and life.
In addition to his investment and entrepreneurial pursuits in the life sciences and the tech world, Bill also monetized his creative proclivities and personal passions in the business of cycling and outdoor sports and adventure, by building and managing from the ground-up a 22-person independent sales rep network selling to bike shops, ski & snowboard shops, and specialty outdoor retailers across much of the U.S.
Prior to Convergent, Bill served as VP, Business Development at Bio-Imaging Technologies, Inc., where his original idea for Convergent Ventures was born. As both a concept and a NASDAQ-listed company, Bio-Imaging Technologies was a perfect example of technology convergence, representing a "coming together", or a merging, of physics, engineering, biology, and medicine. As the seventh employee and first business person to join Bio-Imaging, Bill was responsible for business development, marketing, sales, and investor relations for the company during its critical early years. Earlier in his career, Bill worked in product management and new product development in the pharmaceutical and consumer healthcare products industry. Bill began his career in New York, managing pharmaceutical accounts at Grey Medical Advertising.
Bill has been a non-profit leader, holding regional and national board positions, including several chairmanships, with the American Technion Society, the Israel Cancer Research Fund, the Dartmouth Club of Los Angeles, and the Columbia Business School Club of Southern California.